Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Frasers calls for suspension of Boohoo vice chair Mahmud Kamani

(Sharecast News) - Retail conglomerate Frasers Group has written an open letter to Boohoo, calling for the suspension of executive vice chair and co-founder Mahmud Kamani and requesting an independent investigation into loans he made to the fast fashion company's suppliers. The criticism follows an article published by the Telegraph last week which alleged that Kamani made loans to suppliers through an independent private company he co-owned.

The loans were then reportedly repaid through a scheme whereby funds were taken from Boohoo and instead deposited into Kamani's personal accounts or the accounts of other companies he owns.

Kamani, who owns a 12.5% in the company he co-founded in 2006, is also alleged to have engaged in aggressive tactics to collect payments from one particular supplier, according to the Telegraph. These included demanding discounts for late payments and threatening to cancel orders if the supplier raised its prices.

"These allegations are very serious and damaging to the reputation of boohoo. If proven, it appears that Mr Kamani may have breached his duties as a director of boohoo and could also have committed various criminal offences," Frasers said in a letter from its legal advisers, White & Case.

The letter detailed alleged breaches of the Companies Act 2006, Fraud Act 2006 and Theft Act 1968, calling for an external and independent probe of Boohoo's operations.

"Frasers also asks that boohoo suspends immediately any roles or responsibility held by Mr Kamani and any of his associates involved in this matter, pending outcome of the independent investigation," said Frasers, which owns a 27% stake in Boohoo.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.